Necroptosis in inflammatory bowel disease and other intestinal diseases

被引:33
|
作者
Li, Sha [1 ]
Ning, Long-Gui [1 ]
Lou, Xin-He [1 ]
Xu, Guo-Qiang [1 ]
机构
[1] Zhejiang Univ, Dept Gastroenterol, Affiliated Hosp 1, Coll Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China
关键词
Inflammatory bowel disease; Necroptosis; Inflammation; Colorectal cancer; Intestinal infectious diseases; Drug therapy; Receptor interacting protein kinase 1 inhibitor; CELL-DEATH; TNF; APOPTOSIS; NECROSIS; KINASE; CASPASE-8; RIPK3; ROLES; CONTRIBUTES; INDUCTION;
D O I
10.12998/wjcc.v6.i14.745
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
For a long time, it was believed that apoptosis and necrosis were the main pathways for cell death, but a growing body of research has shown that there are other pathways. Among these, necroptosis, a regulatory caspase-independent, programmed cell death pathway, is supposed to be of importance in the pathogenesis of many diseases. The mechanism of regulating, inducing and blocking necroptosis is a complex process that involves expression and regulation of a series of molecules including receptor interacting protein kinase 1 (RIPK1), RIPK3, and mixed lineage kinase like protein. By blocking or downregulating expression of key molecules in the necroptotic pathway, intestinal inflammation can be affected to some extent. In this paper, we introduce the concept of necroptosis, its main pathway, and its impact on the pathogenesis of inflammatory bowel disease (IBD) and other intestinal diseases, to explore new drug targets for intestinal diseases, including IBD.
引用
收藏
页码:745 / 752
页数:8
相关论文
共 50 条
  • [1] Necroptosis in inflammatory bowel disease and other intestinal diseases
    Sha Li
    Long-Gui Ning
    Xin-He Lou
    Guo-Qiang Xu
    World Journal of Clinical Cases, 2018, (14) : 745 - 752
  • [2] Necroptosis Is Active in Children With Inflammatory Bowel Disease and Contributes to Heighten Intestinal Inflammation
    Pierdomenico, Maria
    Negroni, Anna
    Stronati, Laura
    Vitali, Roberta
    Prete, Enrica
    Bertin, John
    Gough, Peter J.
    Aloi, Marina
    Cucchiara, Salvatore
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (02): : 279 - 287
  • [3] Inflammatory Bowel Disease and the Risk of Other Autoimmune Diseases
    Wilson, J. C.
    Furlano, R.
    Jick, S.
    Meier, C.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S410 - S411
  • [5] INTESTINAL MICROBIOTA AND INFLAMMATORY BOWEL DISEASES
    Ciocoiu, Manuela
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2020, 124 (01): : 5 - 13
  • [6] Intestinal microbiota and inflammatory bowel diseases
    Eun, Chang Soo
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (09): : 588 - 595
  • [7] The intestinal microbiota in inflammatory bowel diseases
    Misselwitz, Benjamin
    Haller, Dirk
    INNERE MEDIZIN, 2025, 66 (02): : 146 - 155
  • [8] The Intestinal Microbiota in Inflammatory Bowel Diseases
    Sartor, R. Balfour
    NUTRITION, GUT MICROBIOTA AND IMMUNITY: THERAPEUTIC TARGETS FOR IBD, 2014, 79 : 29 - 39
  • [9] The role of amino acid metabolism in inflammatory bowel disease and other inflammatory diseases
    Zheng, Xiaowen
    Zhu, Yi
    Zhao, Zihan
    Chu, Ying
    Yang, Wenjing
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] The Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis in Inflammatory Bowel Disease, Colorectal Cancer, and Intestinal Injury
    Zhou, Ping
    Zhang, Shun
    Wang, Maohua
    Zhou, Jun
    BIOMOLECULES, 2023, 13 (05)